- Filed
- May 13, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 30, 2025 | 2.81M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $340.83K |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $376.19K |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $464.93K |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $427.03K |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | 1.6M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $2.49M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | 1.03M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $2.63M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $2.34M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $2.3M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $2.83M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $2.67M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $4.21M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $5.03M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $4.53M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $5.18M |
| Sga Expense | Q1 2025 · Mar 31, 2025 | $1.09M |
| Sga Expense restated | Q1 2025 · Mar 31, 2024 | $1.33M |
| Shares Diluted restated | Q1 2025 · Mar 31, 2024 | 2.02M sh |
| Operating Cash Flow restated | Q1 2025 · Mar 31, 2024 | −$1.29M |
| Eps Diluted restated | Q1 2025 · Mar 31, 2024 | −$0.64 |
| Eps Basic restated | Q1 2025 · Mar 31, 2024 | −$0.64 |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $188.4K |
| Net Income restated | Q1 2025 · Mar 31, 2024 | −$1.29M |
| Operating Income restated | Q1 2025 · Mar 31, 2024 | −$1.33M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $181.88K |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $164.89K |
| Revenue | Q1 2025 · Mar 31, 2024 | $346.77K |